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Both B and T lymphocytes interact with antigens in a highly specific fashion. 
The most direct demonstration of lymphocyte recognition of antigen has been 
the in vitro demonstration of antigen-binding cells obtained from immune and 
nonimmune individuals. However, while antigen-binding B cells can be dem- 
onstrated readily, direct visualization of antigen-binding T cells has been more 
problematic (1). Binding of soluble antigens by T  cells has been particularly 
difficult to demonstrate and was thought to be due to  a  low site density of 
antigen-specific receptors  in  the  T-cell  membrane  (1,  2).  It  is  more  likely 
however, that the difficulty in demonstrating binding of soluble antigen by T 
cells is due to particular temperature and antigen concentration requirements 
requisite for antigen binding to occur (3, 4). 
More success in demonstrating antigen-binding T cells in immune or nonim- 
mune animals has been achieved when T  cells bind antigen in solid phase; 
either soluble antigen linked to fibers (5) or cell membrane-associated antigens 
(6-8).  However,  immune T  cells  which  bind  heterologous erythrocytes  (T- 
rosette-forming cell, T-RFC)  1 differ from their B-cell counterparts in that they 
are  highly unstable  and  dissociate  rapidly  in  vitro  (9). These  observations 
suggest that the avidity ofT-cell antigen receptors is lower than B-cell receptors 
and/or the physiology of the lymphocyte antigen interaction is different for T 
and B cells. 
In the present study we sought to examine in detail the requirements for the 
generation of immune rosette-forming T cells so that functional characterization 
of these cells might be attained. It has previously been suggested that some T- 
RFC function as effector cells for delayed-tape hypersensitivity to sheep eryth- 
rocytes (SRBC) (10). Our results indicate that T-RFC belong to a distinct minor 
subset of T cells which adhere to nylon wool. Although some of the T-RFC may 
be involved in delayed-type hypersensitivity (DTH) reactions, the function of 
the majority of T-RFC  remains unknown.  However,  there are  a  number of 
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similarities  between T-RFC  and two interacting regulatory  T-cell  subclasses 
recently described by Tada (11),  and we suggest they may indeed be the same 
cells. 
Materials and Methods 
Mice.  Mice were 6-8 wk old male BDF1  (C57B1/6  x  DBA/2) from The Jackson Laboratory, 
Bar Harbor, Maine. They were rested 1 wk in our animal facilities before use. 
Immunization  and  Cyclophosphamide  Treatment.  Mice  were  anesthetized  with  ether  and 
immunized  by  intravenous  injection  of  0.2  ml  freshly  washed  SRBC  or  horse  erythrocytes 
(HRBC) (Colorado Serum Co., Denver, Colo.) in sterile pyrogen-free saline (Abbott Laboratories, 
North Chicago,  Ill.).  Unimmunized Controls received intravenous injections of saline.  In some 
experiments groups of mice received an intraperitoneal injection of freshly prepared cyclophos- 
phamide (Mead Johnson & Co., Evansville, Ind.) in saline. Two doses were employed: 20 mg/kg 1 
day before immunization or 200 mg/k.  g 2 days before immunization (12). 
Elicitation  of DTH.  4 days after immunization, mice (five to six/group) were injected in the 
ventral footpad with 0.03 ml of 20% erythrecytes (RBC). Footpad thickness was measured with a 
micrometer before testing and at 24 and 48 h  as previously described (12).  The percent increase 
in footpad thickness was calculated and the Student's t  test was used to compute the statistical 
significance (P <  0.05) between groups. Recipients of spleen cells from immunized donors were 
tested with 50% RBC. 
Preparation  of Cell  Suspensions.  Spleens  of  mice  were  removed  into  chilled  Dulbecco's 
calcium,  magnesium-free,  phosphate-buffered saline  (DPBS)  pH  7.2  or  Hank's  balanced  salt 
solution and were disrupted by either three strokes in a loose fitting tissue grinder or by pressing 
the spleens between two frosted glass microscope slides.  Erythrocytes were removed by either 
hypotonic lysis for 5  s  in distilled water followed by washing in DPBS or by lysis with 0.83% 
NH4CI.  Cellular debris was removed by layering the cells over 0.5 ml fetal calf serum  (FCS) 
and incubation for 5 min at 4°C.  The buffer layer containing the cells was washed three times in 
cold DPBS before use.  In most experiments spleens from each mouse in a  group (two to three/ 
group)  were  pooled  and  rosette  assays  were  done  on  the  pooled  suspensions.  In  transfer 
experiments,  4  days  after  donor  immunization,  cells  were  harvested  in  medium  RPMI  1640 
(Grand Island Biological Co.,  Grand Island, N.  Y.) containing penicillin, streptomycin, and 5% 
FCS. After washing, various doses of cells were transferred intravenously in 0.5 ml medium and 
recipients were footpad tested the following day. 
Separation of Nylon Adherent and Nonadherent  Cells.  The nylon column method of Julius et 
al.  (13)  was employed.  The nylon was prepared as previously described (14)  and 1 ml of spleen 
cell suspension was applied to the column per 0.5 g of nylon at a  concentration of 5  x  107/ml in 
media RPMI 1640  containing 5% FCS.  After incubation at 37°C  x  45 min the nonadherent cells 
were  eluted  with  fresh  37°C  media  and  then adherent  cells  were  recovered  by  agitating the 
nylon.  In  general,  80%  of the  cells  applied  were  recovered;  they  were  >95%  viable  by  dye 
exclusion test, and nonadherent cells accounted for 15-20% of recovered cells. Nylon nonadherent 
cells were considered to be a subpepulation of relatively pure T cells as >95% were killed by anti- 
Thy-1 serum and complement and <2% had surface immunoglobulin as detected by an indirect 
fluorescent anti-immunoglobulin assay (14). 
Treatment with Anti-Thy 1.1 Serum and Complement.  Splenic lymphoid cells were suspended 
in DPBS at a concentration of 2 x  107 cells/ml. AKR anti-C3H Thy 1.1 serum was added to a final 
concentration of 1:20 and the cells were incubated for 30 rain at 4°C.  The cells were then washed 
once, resuspended in medium RPMI 1640 to 2 ×  107 cells/ml, and guinea pig serum was added as 
a  source of complement to a  final concentration of 1:30.  The cells were incubated for 1 h  at 37°C 
and then washed two times with chilled DPBS. Normal AKR serum served as a  control in these 
experiments. The percent of rosette-forming cells (RFC) sensitive to treatment with anti-Thy 1.1 
+  complement was calculated as: 
total no. RFC recovered after treatment with anti-Thy 1.1 +  complement ×  100 
total no. RFC recovered after treatment with normal AKR serum 
Rosette Assay.  Two methods were used for the enumeration of rosotte-forming cells (RFC). 1392  NYLON  ADHERENT  ANTIGEN-SPECIFIC  ROSETTE-FORMING  T  CELLS 
CENTRIFUGATION ASSAY.  A modification of the method of Elliot and Haskill (9) was employed. 
Spleen cells were suspended in 1 ml DPBS at a concentrati(~n of 2  ×  107 cells/ml. SRBC or HRBC 
(0.05 ml of a  10% suspension) were added and the mixture was centrifuged at 4,000 rpm for 3 min 
in 10  ×  75 mm round-bottomed tubes at 4°C  in a  Sorvall RC-5 centrifuge (Sorvall, Ivan, Inc., 
Norwalk, Conn.). Supernates were removed, the pellets were held at 4°C for 30-45 min, and then 
were resuspended to 2  ×  107/ml in DPBS which contained 0.1% (vol/vol) glutaraldehyde (Fisher 
Scientific Co., Pittsburgh, Pa.). This method was optimal for demonstrating thymus-derived RFC 
(T-RFC). 
Iscum~vIos  MZTHO1).  The method of Zaalberg et al.  (15)  was employed.  Spleen cells were 
suspended  in  DPBS  to  a  concentration  of  107  cells/ml.  SRBC  or  HRBC  (0.1  ml  of  a  10% 
suspension) was added and the mixture was incubated (in 10  ×  75 mm round bottom tubes) for 1 
h  at 37°C  at a  45  ° angle. The tubes were then transferred to a  4°C refrigerator, held overnight, 
and RFC were enumerated the following day. RFC prepared by centrifugation were resuspended 
gently with a  Pasteur pipette.  RFC prepared by incubation were resuspended by gently rolling 
the tubes. RFC were enumerated in an improved Neubauer hemocytometer (American Optical 
Corp., Buffalo,  N.Y.) at ×200 magnification.  The entire  chamber was scanned (approximately 
18,000  cells).  Nucleated cells  binding  more than four  erythrocytes  were scored  as a RFC. 
Results 
Effect of Glutaraldehyde  on Rosette-Forming Cells.  Our preliminary experi- 
ments  were  designed  to  enumerate  RFC  in  spleens  of mice  receiving  an 
intravenous low dose of SRBC (0.01%, about 2  x  10  ~ RBC) that was known to 
be optimal  for the  induction  of DTH  (16-18).  At this  antigen  dose it seemed 
likely that elevated numbers of T-RFC would be detected. RFC were prepared 
by centrifugation  and resuspension  in DPBS alone.  In some cases a  three to 
fivefold increase in RFC above that found in control mice was observed, but the 
results  were  quite  variable.  Moreover,  if  the  formed  RFC  were  held  in 
suspension for as short a  time as 10 min at 4°C the number of RFC decreased 
by 50-80%.  In contrast,  mice which were immunized i.v. with 10% SRBC had 
weak DTH responses and stable RFC. 
Rosettes in mice receiving optimal  intravenous  immunizing  doses for DTH 
were found to be stabilized  by fixation  with glutaraldehyde,  as described by 
Elliot and Haskill  (9).  Pellets containing  rosettes were resuspended in DPBS 
containing various concentrations of glutaraldehyde and RFC were enumerated 
after incubation for 5 min at 4°C. As shown in Fig. 1 only a modest increase in 
RFC  above  background  was  observed  when  RFC  were  prepared  without 
glutaraldehyde  (1,100 RFC/106 spleen cells from mice immunized with 0.2 ml of 
0.01% SRBC vs 700 RFC/106 in mice receiving saline).  Inclusion of glutaralde- 
hyde with DPBS resulted in a  significant increase in detection of RFC in the 
immune  cell  population,  0.2-2.0%  glutaraldehyde  being  optimal.  Moreover, 
glutaraldehyde-fixed  rosettes did not deteriorate  when  incubated  for 24  h  at 
4°C.  In contrast,  glutaraldehyde fixation caused no significant increase in the 
background  RFC  in  spleens  from  unimmunized  mice  (Fig.  1)  or  in  mice 
receiving 10% SRBC i.v.  (data not shown). Spleen cells incubated with glutar- 
aldehyde for 10 min at 4°C before centrifugation with RBC formed no RFC. 
Antigen  Specificity  of RFC  in  Mice Receiving Intravenous  Immunization 
with  Low  Doses  of RBC.  The  results  presented  above  indicate  that  the 
spleens of mice receiving 0.01% SRBC contain elevated numbers of cells capable 
of binding SRBC 4 days after immunization.  The antigen-binding  specificity of 
these cells was determined  by immunizing  groups of mice with either  0.01% R. 
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FIG.  1.  Stabilization of rosette formation by glutaraldehyde. Spleen cells obtained 4 days 
after immunization of mice with 0.01% SRBC were mixed with SRBC and allowed to form 
rosettes.  After incubation at 4°C  the cells were resuspended in various concentrations of 
glutaraldehyde  in  DPBS  and RFC  were  enumerated.  Closed;  RFC  in  immunized mice. 
hatched bar; RFC in mice receiving saline only. 
TABLE  I 
Antigen Specificity  of RFC in Mice Immunized Intravenously 
with Low Doses of RBC 
RFC/spleen 
Immunization 
SRBC  HRBC 
Saline  5,000  8,000 
0.01% SRBC  17,000  1,500 
0.01% HRBC  3,900  86,000 
Spleens  were  removed  from  three  mice  in  each  group  4  days  ai~er 
immunization and pooled for the preparation of cell suspensions used 
in the rosette assay. 
SRBC or HRBC. 4 days later spleen cells were assayed for RFC by using both 
SRBC and  HRBC in  each  group.  Immunization  with  SRBC  elevated splenic 
RFC over threefold from a background of 5,000/spleen to 17,000/spleen but did 
not raise the numbers of cells binding HRBC (Table I). In fact, the number of 
HRBC-binding cells was reduced from 8,000/spleen to 1,500/spleen.  Immuniza- 
tion with HRBC raised the number of HRBC-binding cells approximately 10-fold 
but had no effect on RFC-binding SRBC. The ability of HRBC to elicit specific 
RFC at low antigen doses was found to be consistently better than SRBC. The 
majority of RFC detected at this and lower doses of either HRBC or SRBC were 
T cells (see below). 
Effect  of Antigen  Dose  on  Rosette-Forming  Cells.  We  next  examined  in 1394  NYLON  ADHERENT  ANTIGEN-SPECIFIC  ROSETTE-FORMING  T  CELLS 
detail the relationship between antigen dose and the number and type of RFC 
elicited.  Mice received from  2  x  103 to  2  x  108  SRBC i.v.  and  spleens were 
harvested 5 days later. Portions of the cell suspensions were treated with anti- 
thy  1.1  serum  and  complement  and  antiserum-treated  and  untreated  cell 
populations  were  assayed  for  RFC  by  both  centrifugation  and  incubation 
assays.  The  number  of T-RFC  was  obtained  by  multiplication  of the  total 
number  of RFC  in  the  untreated  cell  populations  by  the  percent  of RFC 
eliminated by anti-Thy 1.1 treatment.  The remainder were considered B-RFC. 
As shown in Fig.  2 A,  no rise in centrifuged total  RFC-binding SRBC was 
evident  until  administration  of at  least  0.01%  (2  ×  105) SRBC.  At  higher 
immunizing doses the number of RFC rose rapidly reaching a peak at 1% (2  × 
107) SRBC. However, when mice were immunized with low doses of RBC and T 
and  B-RFC  were  enumerated  separately,  changes  in  the  numbers  of these 
subsets of RFC (relative to background levels) were observed. Thus, the T-RFC 
levels in mice receiving saline were usually only approximately 15-20% of the 
total number of background RFC. As shown in Fig. 2 A  the number of T-RFC 
rose approximately threefold with injection of as few as 2 x  103 SRBC (0.0001%). 
The number of T-RFC remained constant up to administration  of 0.01% SRBC 
and comprised at least 60% of the total RFC population. The number of T-RFC 
rose again and plateaued when (0.1-1.0%) SRBC were injected. However, 10% 
SRBC caused an 80% reduction in the number of T-RFC from levels attained 
with  1%  SRBC.  In  contrast,  injection  of 0.0001%  SRBC  resulted  in  a  44% 
reduction in the number of B-RFC relative to background levels. The number 
of B-RFC  began  to  rise  from  this  level  (9,000/spleen)  at  0.01%  SRBC  and 
continued to rise until  1.0% SRBC where the levels were approximately sixfold 
higher than T-RFC. 
Substantially  similar :results  were obtained  when  mice were injected with 
HRBC. However, as shown in Fig. 2 B the increase in total RFC began at 2  x 
104 HRBC (0.001%)  and peaked at 0.1% erythrocytes. T-RFC began to increase 
at 2  x  103 HRBC and peaked at 2  x  106 HRBC. Higher doses of HRBC (more 
than 2  x  106) resulted in substantial decreases in T-RFC levels. Similarly,  B- 
RFC levels fell to 25% of background levels at low immunizing doses (2  x  103 
HRBC) and did not rise significantly until 2 x  1@ HRBC were injected. B-RFC 
levels peaked at 2  x  107 HRBC and fell somewhat at 2  x  10  s HRBC. 
In contrast to the results obtained when RFC were prepared by centrifuga- 
tion,  RFC  assessed by the  incubation  assay  presented  a  markedly  different 
picture (Fig. 2 C). At no point in the dose-respense curve were significant num- 
bers of T-RFC observed by the incubation  assay and consequently only total 
RFC are shown. As was observed when B-RFC were detected by the centrifuga- 
tion technique the number of B-RFC detected by incubation fell dramatically 
from background levels when 0.0001-0.01% SRBC were injected. Elevated num- 
bers of RFC above normal background levels were observed when 0.1% SRBC 
were injected and peak levels were obtained with 1-10%  SRBC. 
The results presented above indicate that the antigen dose requirements for 
the generation ofT and B-RFC are markedly different. The population dynamics 
of T and B-RFC relative to antigen dose and regardless of absolute numbers is 
shown in Fig. 3.  It can be seen that with very low dose immunization,  T-RFC 
are  selectively  generated  and  B-RFC  are  suppressed.  This  is  particularly R.  E.  CONE,  R.  K.  GERSHON,  AND  P.  W.  ASKENASE 
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Fro. 2.  Dose-response  of splenic  RFC  induc- 
tion.  Mice received  SRBC  (2 A, 2 C)  or HRBC 
(2B) and total, Thy  1  + and Thy  1-  RFC were 
enumerated  4  days  after  immunization.  RFC 
were  prepared by  centrifugation and  fixation 
(2 A, 2 B) or incubation at 37°C for 2 h and over- 
night  at 4°C  (2C).  Figs.  2A  and  B:  (x ..... x) 
total RFC,  (A--A)  Thy  1-negative  (B) RFC, 
(O--[:3)  Thy 1  + RFC. Fig.  2C: (@---e)  total  RFC. 
Data represents one of three separate experi- 
ments with similar results. Each point repre- 
sents the RFC  obtained  from a pool of three 
spleens. 
evident when  2  ×  103  -2  x  104 HRBC  are administered. The proportion of T- 
RFC in the spleen shifts from 15-20% background levels to more than 90%.  As 
the dose of antigen is increased, B-RFC are generated such that the proportion 
of T-RFC vs. B-RFC becomes reversed at high antigen doses. 1396  NYLON  ADHERENT  ANTIGEN-SPECIFIC  ROSETTE-FORMING  T  CELLS 
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FIG.  3.  Percent Thy 1 + splenic RFC as a  function of antigen dose.  Mice were immunized 
with SRBC or HRBC and spleens were assayed for RFC 4 days after immunization. Thy 1  ÷ 
RFC were assessed by determining the percent of RFC reduction when spleen cells were 
treated  with  anti-Thy  1  antiserum  and  C'  before  rosette  formation.  (O---O)  TRFC  to 
SRBC,  (©--©)  TRFC  to  HRBC.  Data represents the results obtained in three separate 
experiments. 
Fractionation  of T-RFC and B-RFC on Nylon  Wool  Columns.  From the 
above it is apparent that immunization of mice with low doses of erythrocytes 
selectively induces the generation of T-RFC.  To document this point further 
splenic lymphocytes from immune and nonimmune mice were applied to nylon 
wool  columns  to  separate  nylon  adherent  and  nonadherent  cells  (13). In 
general, approximately 15-20% of the cells were nonadherent and these were 
95-98% T cells.  However, as shown in Table II the RFC population was almost 
completely adherent  to  nylon  regardless  of the  dose  of antigen  used  for 
immunization. Thus,  in 0.01% SRBC-immune mice 70%  of the RFC  were T 
cells yet nearly all of these adhered to nylon. When mice received 10% SRBC, 
only 15%  of the total RFC  population were T  cells, but 91%  of these T-RFC 
were nylon adherent. In this case the majority of adherent RFC were B cells. 
In these experiments we also enumerated RFC  which were induced in mice 
which received  10%  SRBC  and  200  mg/kg cyclophosphamide 2  days before 
injection of antigen. In such mice antibody production is abrogated and DTH is 
elicited (12). In cyclophosphamide-treated mice 81%  of the RFC were T  cells 
and 98% of these T-RFC adhered to nylon. It should be noted that the total 
number  of T-RFC  in  cyclophosphamide-treated mice  immunized with  10% R.  E.  CONE,  R.  K.  GERSHON,  AND  P.  W.  ASKENASE 
TABLE II 
Adherence of T-RFC and B-RFC to Nylon Wool 
1397 
SRBC ira-  Cyclophospha-  Nylon adherent  Nylon nonadherent 
mide pretreat-  Total RFC 
rnuniza- 
tion  ment, 200 rag/  Thy 1 +  Total re-  Thy 1 ÷  Total re-  Thy 1 ÷ 
kg  covered  covered 
%  %  % 
0.01%  -  70  92  66  8  97 
10%  -  15  91  NT*  9  NT 
10%  +  81  98  88  2  100 
Saline  -  20  99  19  1  100 
Data represents the pooled results obtained in three separate experiments. 
* NT,  not tested. 
SRBC was not significantly different from that obtained just by immunization 
with 0.01% SRBC.  Similar results to those presented in Table II were obtained 
when HRBC were utilized as antigen (data not shown). 
Development of  RFC and Delayed Hypersensitivity.  In addition to assessing 
the development of T  and  B-RFC  as  a  function of antigen dose,  we tested 
concurrently  the development of DTH to the immunizing antigen. Thus, 4 days 
after immunization some mice were assayed for RFC and others were challenged 
in the footpad with erythrocytes, and swelling was measured 24 h  later. The 
results shown in Fig.  4  demonstrate that maximum footpad reactions were 
obtained with 104-SRBC and 105-HRBC where T-RFC were selectively induced 
relative to  B-RFC.  At antigen doses yielding maximum numbers of B-RFC, 
(see Figs. 2 A and B) delayed hypersensitivity was reduced or absent. Although 
the  increase  in  T-RFC  paralleled  the  increase  in  delayed hypersensitivity 
between  103  and  105  erythrocytes, peak  numbers  of T-RFC  were  however, 
observed at antigen doses that resulted in reduced-delayed hypersensitivity. 
There is the suggestion of a shoulder in the dose-response curve for T-RFC  at 
the antigen dose resulting in maximum-delayed hypersensitivity indicating a 
possible biphasic nature to the dose-response curve. This is particularly evident 
for SRBC  (Fig. 4 A). 
Effect of Cyclophosphamide  Pretreatment  on  the  Generation of T  and B- 
RFC.  Previous findings  (16-18) have shown that  mice immunized intrave- 
nously with 0.01% RBC have optimal DTH responses and no hemagglutinating 
antibody responses at day 4.  Mice receiving higher immunizing doses have 
progressively diminished DTH reactions and progressively increased antibody 
responses. DTH can be augmented in these latter mice by pretreatment with 
cyclophosphamide in high doses (200 mg/kg), which are B-cell depleting, or in 
low doses (20 mg/kg), which do not affect antibody responses (12). Since high 
doses of cyclophosphamide will facilitate T-RFC formation in mice receiving 
10% SRBC  (Table II),  we next compared the total RFC and the T and B-RFC 
responses in controls vs. mice pretreated with 20 mg/kg cyclophosphamide and 
immunized with various doses of HRBC.  The continuous rise in B-RFC and T- 
RFC over the immunizing dose range of 103-10  e HRBC was similar in control 
vs. cyclophosphamide-treated  mice. However, as shown in Fig. 5, the significant 
decline in T-RFC at the highest immunizing dose (10  v, 1% RBC) was prevented 1398  NYLON  ADHERENT  ANTIGEN-SPECIFIC  ROSETTE-FORMING  T  CELLS 
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FxG.  4.  Dose-response  of Thy  1 + RFC  and elicitation of DTH.  Mice received SRBC  (4A) 
or  HRBC  (4B)  4  days  before  either  enumeration  of  RFC  or  footpad  challenge  with 
erythrocytes.  Fig.  4A:  (n--n),  Thy  1 +  RFC,  (x--x)  24  h  footpad  swelling,  percent 
increase.  Fig.  4B:  (O--O) Thy  1 + RFC,  (x--x)  24 h  footpad  swelling,  percent  increase. 
RFC  results  are  the  number  of RFC  enumerated  in  a  pool  of three  spleens.  Footpad 
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FIG.  5.  Effect  of cyclophosphamide treatment on the induction of Thy  1  + and Thy  l- 
negative RFC in high antigen dose-immune mice. Mice received 20 mg/kg cyclophospha- 
mide  1  day  before  immunization with  1  x  107  HRBC.  4  days  after  injection of HRBC 
spleens were harvested and Thy 1  + and Thy  1-negative RFC  were enumerated.  Hatched 
bar; Thy-l-poaitive. Closed bar; Thy 1-negative RFC. Data are representative of one of two 
experiments with similar results. 
by cyclophosphamide pretreatment. Thus, 20 mg/kg cyclophosphamide did not 
affect B-cell responses over immunizing doses that were optimal or supraopti- 
mal for DTH. However, at the highest immunizing dose,  20 mg/kg cyclophos- 
phamide affected T-cell responses. DTH was augmented and the decline in T- 
RFC was abolished. 
Nylon  Wool  Column  Fractionation  of  Spleen  Cells  Transferring 
DTH.  Although nylon nonadherent cells are a relatively pure subpopulation 
of T cells, the results of the previous section indicate that antigen-specific T- 
RFC are largely adherent to nylon wool. The separation of these T-cell subsets 
by nylon adherence thus affords a  means to determine the capacity of thes,~ 
subsets to transfer DTH. Table HI shows one of three similar experiments in 1400  NYLON  ADHERENT  ANTIGEN-SPECIFIC  ROSETTE-FORMING  T  CELLS 
TABLE  III 
Transfer of DTH with Immune Spleen Cells Fractionated on 
Nylon Wool Columns 
No.  cells trans-  24 h  footpad 
Transferred spleen cell type  ferred/mouse  swelling  +_  SE 
% 
Whole  40  ×  106  33  ±  1 
Whole  20  x  106  25  ±  3 
Whole  10  ×  106  20  ±  4 
Whole  5  ×  106  17  ±  2 
Nylon adherent  20  x  106  31  ±  3 
Nylon adherent  10  ×  106  22  ±  1 
Nylon adherent  5  x  106  21  ±  2 
Nylon adherent  2.5  ×  106  17  _+  1 
Nylon adherent  1.25  ×  106  18  ~  1 
Nylon nonadherent  40  x  106  35  ~  3 
Nylon nouadherent  20  x  106  25  +_  2 
Nylon nonadherent  10  x  106  26  ±  5 
Nylon nonadherent  5  x  106  20  __  2 
Nylon nonadherent  2.5  ×  106  18  ±  1 
Nylon nonadherent  1.25  ×  106  20  _*  4 
Nil  9  ~  3 
Donors  were  immunized  with  0.01%  SRBC  and  cells  were  harvested 
and transferred at day 4. 
The  following  day  recipients  (five/group)  and  a  control  group  were 
footpad  tested  with  50%  SRBC.  Significant  responses  were  elicited in 
all recipients. 
%  =  percent  increase  in  footpad  thickness  relative  to  unchallenged 
mice. 
which  whole  spleen  cells,  nylon  nonadherent  cells,  and nylon  adherent  cells 
were all able to transfer DTH.  Adherent or nonadherent cells were equivalent 
in the ability to transfer DTH when tested in a limiting dilution assay. In both 
instances  only  1.25  ×  106 cells  from donors immunized just 4  days previously 
with  only  2  ×  105  SRBC  were  competent  to transfer  DTH.  This  represented 
about 2%  of the  cells  in a  donor spleen.  For both adherent  and nonadherent 
cells there was a  broad plateau in the dose-response curve so the 8-fold range 
from 1.25-10  ×  l0  s cells produced equivalent transfers of DTH. It was concluded 
that  nylon  adherent  and  nonadherent  cells  could  transfer  DTH  in  small 
numbers and that in either case cells  containing very few antigen-specific  T- 
RFC were effective in systemic transfer of DTH. 
Discussion 
We  have found that  antigen-specific  rosette-forming  T  cells  can be demon- 
strated  in mice immunized with a  wide dose-range  of sheep or horse erythro- 
cytes.  The T-RFC induced by erythrocyte  immunization differ from B-RFC in 
the stability of lymphocyte-RBC interaction and in dose-response requirements. 
We found, in confirmation of the observations of Elliot and Haskill  (9), that T- R.  E.  CONE,  R.  K.  GERSHON,  AND  P.  W.  ASKENASE  1401 
RFC are highly unstable.  Once T-RFC are formed they will deteriorate within 
10 min of suspension unless fixed with glutaraldehyde.  In fact, incubation of T 
cells with SRBC under B-cell rosetting conditions  (19) results in complete loss 
of T-RFC.  Moreover, incubation of splenic lymphocytes with SRBC for 15 min 
in suspension before centrifugation will result in a  similar disappearance of T- 
RFC. These results suggest that T-cell erythrocyte interactions  in suspension 
may result in some active process which releases the erythrocyte from the cell 
surface,  perhaps  with shedding or internalization  of the antigen  receptor.  In 
support of this contention Elliot and Haskill (9) have shown that suspension of 
T  rosettes  in  buffers  containing  sodium  azide  stabilizes  rosette  formation. 
However, pretreatment  of lymphocytes with glutaraldehyde before addition of 
erythrocytes abrogates the formation of T-RFC. Such treatment may cross-link 
the antigen receptor at the cell surface or fix the cell surface in such a  way as 
to either prevent antigen binding or membrane movement required for rosette 
formation. 
The  dose requirements  for the  induction  of T  and B-RFC were found to be 
distinctive  at  both  low  and  high  antigen  doses.  At  extremely  low  doses  of 
antigen,  T-RFC  are  selectively induced.  The  dose of antigen  required  for B- 
RFC induction is at least 10-fold higher than that required for T-RFC. Moreover, 
at antigen doses resulting in selective T-RFC induction,  B-RFC are suppressed 
below normal background levels. This reciprocal rise in T-RFC and fall in B- 
RFC  at low antigen  doses can  make  it  appear  as  if no increase  in RFC has 
occurred  unless  T  and  B-RFC  are  enumerated  separately.  The  decrease  in 
background  B-RFC at low antigen  doses may be nonspecific  as suggested by 
the data in Table I.  Immunization  with 0.01%  SRBC caused elevated RFC to 
SRBC, but this was accompanied by a profound decrease in background RFC to 
HRBC.  Above the minimum  B-RFC-inducing dose, B-RFC increase  in linear 
fashion  with  log  increases  in  SRBC.  In  contrast,  the  generation  of T-RFC 
suggests  a  biphasic  response  with  an  increase  in  T-RFC  between 0.001  and 
0.01%,  a  plateau  or shoulder between 0.01  and  0.1%,  and  a  further  increase 
between 0.1 and 1%. It is possible that the biphasic nature of the dose-response 
curve reflects differing optimal doses for the generation of two separate T-cell 
populations. 
The functional role,  if any, these T-RFC may have in the immune response 
is unknown.  Our results indicate that they are not essential for the induction 
or  elicitation  of DTH  response  because:  (a)  maximum  TRFC  responses  are 
found  after  immunization  with  doses of antigen  which  are  1-2  logs  greater 
than  those which produce optimal-delayed hypersensitivity responses and  (b) 
DTH responses can be transferred with cells which pass through nylon columns, 
which are almost totally devoid of T-RFC.  However, DTH responses can also 
be transferred with cells eluted from nylon columns.  Since these cells contain 
T-RFC,  it is possible that T-RFC are a  second type of DTH inducer or effector 
cell. Alternatively T-RFC may act in concert with other T cells in effecting or 
regulating DTH responses. 
While  it  is  possible  that  T-RFC  may  play  some  regulatory  role  in  the 
immune  response,  it  is  clear  that  they  are  not essential  for T-cell-mediated 
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T-RFC  is markedly inhibited by high antigen doses which are known to be 
efficacious in producing suppressor T  cells (20). In addition, the inhibiting 
effect  of  high antigen doses on T-RFC production is  eliminated by pretreatment 
with cyclophosphamide, indicating that T-RFC as well as DTH  effector  cells 
are under suppressor cell  control.  Furthermore, we have been able to show 
significant  suppressor activity  in nylon passed T-cell  populations from animals 
immunized with high doses of  SRBC  (20). 
It is also  clear  that the T-RFC are not essential  for T-cell-mediated helper 
effects  because helper cells  also  pass through nylon columns. Thus, we are left 
with what appears to be an important T-cell  population in that large numbers 
of  T-RFC are  formed after  immunization, yet  no specific  immunological function 
can be assigned to them. However, since  there are a number of similarities 
between T-RFC and certain T-ceU subpopulations described by Tada (11),  it is 
possible  that the two cell  types are either  identical  or closely  related. 
Tada (11)  has described an Ly 2,3 T cell  which acts  to induce suppressor cells 
from the Ly 1,2,3, IJ-positive T-cell pool. Tada finds that both inducer cell and 
its target accepter cell adhere to nylon. It should be noted that our preliminary 
evidence indicates that  all T-RFC can be killed with an  anti-Ly 2 antiserum 
and  a  variable  proportion  are  killed  with  an  anti-Ly  1,  indicating  that  like 
Tada's two cells, our T-RFC are of the Ly 2,3 and Ly 1,2,3 phenotype. Thus, the 
T-RFC  we  have  described  may  be  cells  involved  in  the  fine  tuning  of the 
immune response. Our antigen dose-response studies also suggest the existence 
of two T-RFC  subpopulations,  one of which  is activated  at  very low doses of 
antigen and another which appears at higher doses just before inhibition of T- 
RFC occurs. It would be interesting  if the first population represented the Ly 
2,3  inducer  which  at  the  higher  doses  recruited  or  induced  the  Ly  1,2,3 
acceptor.  The  absence  of T-RFC  found  at  the  higher  doses  could  then  be 
explained by the amplified suppression produced by the interaction  of the two 
aforementioned subpopulations. 
Tada has also  shown that an antigen-specific  factor  passes from the suppres- 
sor inducer cell  to its target, and is probably responsible for the activation of 
the target cell  (11).  It  could be that the receptors  on the T-RFC which bind the 
SRBC  are the same or related molecules to the ones Tada has used to induce 
suppression. It is also  possible  that since  a significant  number of  Fc positive  T 
cells  adhere to nylon (21)  that the antigen-specific  molecule is not necessarily 
made by the T-RFC  but is demonstrable only on the cells  which receive it 
passively. This could explain why  it has been so difficult  to demonstrate 
antigen-binding helper cells  (10).  They may shed or secrete  their  receptors too 
rapidly or too easily to be detected, while only the cells which passively pick up 
these factors or receptors can be demonstrated by antigen binding. 
This raises the question of which cell is making the antigen-specific receptor 
on the T-RFC.  Although  it is possible that T-RFC make their own receptors, 
since T-RFC  are found in the  fraction  of T  cells which is rich  in  Fc-positive 
cells, one must at least consider the possibility that the factor-bearing cells do 
not make their own receptor.  Our results clearly rule out the possibility that 
the antigen-binding receptor is made by a  standard B cell. Thus,  a  significant 
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stimulate any measurable B-cell activity and doses of antigen inducing maxi- 
mum  B-RFC  suppress  T-RFC.  In  addition,  we showed that  at  high  doses of 
antigen,  the  production  of T-RFC  is  markedly  augmented  by pretreatment 
with  doses  of cyclophosphamide  which  eliminate  the  production  of B-RFC. 
Further,  immunization  with  the  low  doses  of antigen  increase  T-RFC  and 
suppress B-RFC. Finally,  no T-RFC are detected under B-cell rosetting condi- 
tions where secretion of Ig might be expected. These results do not rule out the 
possibility  that  there  is  a  specialized  subpopulation  of B  cells  which  make 
antigen-specific  factors  which  are  accepted  by T-RFC.  Alternatively,  as  we 
have suggested above, the T-RFC may passively acquire their specificity from 
products made by other T cells. We are presently testing some of the hypotheses 
we have offered above. 
Summary 
Shortly after intravenous  immunization  of mice with heterologous erythro- 
cytes (RBC) antigen-specific Thy 1  ÷ cells which form rosettes with the immuniz- 
ing RBC (thymic-derived lymphocytes-forming rosettes [T-RFC]) appear in the 
spleen.  These  T-RFC  are  much  less  stable  than  Thy  1-  RFC  (non-thymic- 
derived  [B-RFC])  although  most  if not  all  of both classes  of RFC  adhere  to 
nylon.  T-RFC are induced with low doses of antigen  (which fail to induce B- 
RFC) and are inhibited by higher antigen doses which are optimal for induction 
of B-RFC. Pretreatment of mice with cyclophosphamide prevents the high dose 
inhibition of T-RFC. Although there are many parallels between the production 
of T-RFC  and  delayed-type hypersensitivity  (DTH)  it is unlikely that  the T- 
RFC are essential for DTH reactions since DTH can be transferred with cells 
which pass through nylon, and such cells are almost totally depleted of T-RFC. 
Thus  immunization  can  lead to  the production  of large  numbers  of antigen- 
specific  T-RFC  whose functional  role  in  the  immune  response  is  unknown. 
However,  the  characteristics  of the  T-RFC  suggest  that  they  may  play  an 
important role in amplification of suppressor cell activity. 
Received for publication 6 July 1977. 
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